
Olmirose CH 20mg/12.5mg Tablet
Marketer
Thyone Health Care
Salt Composition
Olmesartan Medoxomil (20mg) + Chlorthalidone (12.5mg)
Overview Olmirose CH 20mg/12.5mg Tablet
Combipress HT 20mg/12.5mg tablets combine two medications to effectively manage hypertension through complementary mechanisms. Untreated high blood pressure significantly increases the risk of serious complications like stroke, heart attack, and kidney disease. Combipress HT 20mg/12.5mg can be taken with or without food; dosage is individualized based on your response and health status. Consistent daily timing is recommended. Continue taking this medication as directed by your physician; discontinuation may raise your risk of cardiovascular events. This medication includes a diuretic, increasing urination, so avoid taking it within four hours of bedtime. Regular use, even when feeling well, maximizes benefits. Hypertension often lacks noticeable symptoms. Common side effects include dizziness, fatigue, nausea, diarrhea, headache, and occasionally, low blood pressure. Increased urination is an expected effect of the diuretic component, integral to blood pressure control. While other side effects are possible, most are infrequent. Consult the patient information leaflet and inform your doctor of any persistent or bothersome side effects; dosage adjustment or alternative medication may be considered. This medication is unsuitable during pregnancy and requires physician consultation if you have kidney or liver impairment, cardiac issues, or diabetes. Alcohol consumption may exacerbate low blood pressure and side effects.
Primary Ingredients of Olmirose CH 20mg/12.5mg Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Olmirose CH 20mg/12.5mg Tablet
Elevated arterial blood pressure
Major Benefits of Olmirose CH 20mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmirose CH 20mg/12.5mg tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Olmirose CH 20mg/12.5mg Tablet:
- Nausea
- Taste change
- Diarrhea
- Upset stomach
- Weakness
- Headache
- Increased blood uric acid
- Dizziness
- Increased blood lipid level
- Electrolyte imbalance
- Decreased blood pressure
- Urinary tract infection
- Renal dysfunction
- Sore throat
- Abnormal liver function tests
- Increased potassium level in blood
How to use Olmirose CH 20mg/12.5mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Olmirose CH 20mg/12.5mg Tablets can be administered with or without food, though consistent timing is recommended.
How Olmirose CH 20mg/12.5mg Tablet works:
Each Olmirose CH tablet (20mg/12.5mg) contains a dual-drug formulation.
SAFETY ADVICE
AlcoholUNSAFE
Concomitant use of Olmirose CH 20mg/12.5mg tablets and alcohol can lead to increased sleepiness.
PregnancyCONSULT YOUR DOCTOR
Using Olmirose CH 20mg/12.5mg tablets during pregnancy is contraindicated due to established risks to the fetus. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Olmirose CH 20mg/12.5mg tablets while breastfeeding is likely inadvisable. Preliminary human evidence indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking Olmirose CH 20mg/12.5mg tablets might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Olmirose CH 20mg/12.5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; the medication is generally unsuitable for such patients.
LiverCAUTION
Patients with hepatic impairment should exercise caution when taking Olmirose CH 20mg/12.5mg tablets, potentially requiring dosage modification. Physician consultation is advised. Olmirose CH 20mg/12.5mg tablets are contraindicated in individuals with severe liver disease.
What if you forget to take Olmirose CH 20mg/12.5mg Tablet :
Should you forget to take your Olmirose CH 20mg/12.5mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Olmirose CH 20mg/12.5mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Heart |
